BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34967552)

  • 1. lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma.
    Wu S; Deng Y; Luo Y; Ye J; Liu Z
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):3741-3753. PubMed ID: 34967552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis.
    Ye J; Wu S; Pan S; Huang J; Ge L
    Oncol Rep; 2020 May; 43(5):1451-1466. PubMed ID: 32323856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Scoring System based on lncRNA Expression for Predicting Survival in Hepatocellular Carcinoma with Cirrhosis.
    Ye J; Li H; Wei J; Luo Y; Liu H; Zhang J; Luo X
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1787-1795. PubMed ID: 32592379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of a competing endogenous RNA network reveals key long noncoding RNAs as potential prognostic biomarkers for hepatocellular carcinoma.
    Ye J; Zhang J; Lv Y; Wei J; Shen X; Huang J; Wu S; Luo X
    J Cell Biochem; 2019 Aug; 120(8):13810-13825. PubMed ID: 30989713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Yan J; Zhou C; Guo K; Li Q; Wang Z
    J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Four-Methylated lncRNAs-Based Prognostic Signature for Hepatocellular Carcinoma.
    Liao LE; Hu DD; Zheng Y
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32784402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma.
    Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C
    Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Long Noncoding RNA Biomarkers for Hepatocellular Carcinoma Using Single-Sample Networks.
    Yu X; Zhang J; Yang R; Li C
    Biomed Res Int; 2020; 2020():8579651. PubMed ID: 33299877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis identifies a long non-coding RNAs-messenger RNAs signature for prediction of prognosis in hepatitis B virus-hepatocellular carcinoma patients.
    Bai Z; Li H; Li C; Sheng C; Zhao X
    Medicine (Baltimore); 2020 Oct; 99(40):e21503. PubMed ID: 33019382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.
    Huang DP; Liao MM; Tong JJ; Yuan WQ; Peng DT; Lai JP; Zeng YH; Qiu YJ; Tong GD
    Aging (Albany NY); 2021 Nov; 13(22):24621-24639. PubMed ID: 34799469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
    Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
    Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.